Literature DB >> 12009328

The NH(2)-terminal propeptides of fibrillar collagens: highly conserved domains with poorly understood functions.

Paul Bornstein1.   

Abstract

The impetus for this review comes from the recent finding that the absence of the majority of the non-triple-helical sequence in the NH(2)-terminal propeptide (N-propeptide) of the pro alpha 1(I) collagen chain fails to generate a significant phenotype in the mouse (Bornstein et al., J. Biol. Chem., 277:2605-2613, 2002). This result is in apparent conflict with those of numerous studies in vitro that have implicated the N-propeptide in a number of processes that are involved in the biogenesis, maturation and function of type 1 collagen. To seek an explanation for this discrepancy, the sequences of the highly conserved, 55-57-amino acid, cysteine-rich repeats (CRR), which constitute the majority of the globular domains in the N-propeptides, were compared among 13 vertebrate species. Surprisingly, the CRR in mice and rats differs substantially from those in other mammalian species. Indeed, the CRR in birds, fish and amphibia are more similar to those of other mammals than are the CRR in rodents. This finding raises the possibility that the mutant mouse, which lacks exon 2 that encodes the CRR in the N-propeptide, might not be an appropriate model in which to study the function of the N-propeptide in other mammals. Alternatively, compensation, possibly by procollagens II or III, could account for the mild phenotype of the exon 2-deleted mouse. Yet another possibility is that the CRR plays a developmental role in the mouse, akin to that recently proposed for the N-propeptide in type IIA procollagen, rather than a function in collagen biogenesis. Some support for the latter possibility is provided by the observation that, on one background, the breeding of heterozygous exon 2-deleted mice generated homozygous mutants at less than the expected frequency. Experiments to examine these possibilities are proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009328     DOI: 10.1016/s0945-053x(02)00008-2

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  13 in total

1.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  Disruption of the developmentally-regulated Col2a1 pre-mRNA alternative splicing switch in a transgenic knock-in mouse model.

Authors:  Renate Lewis; Soumya Ravindran; Louisa Wirthlin; Geoffrey Traeger; Russell J Fernandes; Audrey McAlinden
Journal:  Matrix Biol       Date:  2012-01-09       Impact factor: 11.583

3.  The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.

Authors:  T K Cooper; Q Zhong; M Krawczyk; H-J Tae; G A Müller; R Schubert; L A Myers; H C Dietz; M I Talan; W Briest
Journal:  Vet Pathol       Date:  2010-06-29       Impact factor: 2.221

4.  Quantification of type II procollagen splice forms using alternative transcript-qPCR (AT-qPCR).

Authors:  Audrey McAlinden; Kyu-Hwan Shim; Louisa Wirthlin; Soumya Ravindran; Thomas M Hering
Journal:  Matrix Biol       Date:  2012-09-10       Impact factor: 11.583

5.  The NH2-terminal propeptide of type I procollagen acts intracellularly to modulate cell function.

Authors:  Anush Oganesian; Sandra Au; Jeremy A Horst; Lars C Holzhausen; Athena J Macy; James M Pace; Paul Bornstein
Journal:  J Biol Chem       Date:  2006-10-03       Impact factor: 5.157

6.  Type IIB procollagen NH(2)-propeptide induces death of tumor cells via interaction with integrins alpha(V)beta(3) and alpha(V)beta(5).

Authors:  Zhepeng Wang; Jennifer Bryan; Carl Franz; Necat Havlioglu; Linda J Sandell
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

7.  Molecular properties and fibril ultrastructure of types II and XI collagens in cartilage of mice expressing exclusively the α1(IIA) collagen isoform.

Authors:  Audrey McAlinden; Geoffrey Traeger; Uwe Hansen; Mary Ann Weis; Soumya Ravindran; Louisa Wirthlin; David R Eyre; Russell J Fernandes
Journal:  Matrix Biol       Date:  2013-10-07       Impact factor: 11.583

8.  Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.

Authors:  Christian Bieglmayer; Hans Peter Dimai; Rudolf Wolfgang Gasser; Stefan Kudlacek; Barbara Obermayer-Pietsch; Wolfgang Woloszczuk; Elisabeth Zwettler; Andrea Griesmacher
Journal:  Wien Med Wochenschr       Date:  2012-08-14

9.  Expression in SPARC-null mice of collagen type I lacking the globular domain of the α1(I) N-propeptide results in abdominal hernias and loss of dermal collagen.

Authors:  Lauren Card; Nikki Henderson; Yuhua Zhang; Paul Bornstein; Amy D Bradshaw
Journal:  Matrix Biol       Date:  2010-08-11       Impact factor: 11.583

Review 10.  Alternative splicing of type II procollagen: IIB or not IIB?

Authors:  Audrey McAlinden
Journal:  Connect Tissue Res       Date:  2014-04-18       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.